Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study

INTRODUCTION: DE-089C is a newly developed long-acting formulation of diquafosol ophthalmic solution with less frequent administration (three times daily) than the currently approved and clinically used diquafosol ophthalmic solution (six times daily), hereinafter referred to as DQS. DE-089C is desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Yuichi, Oka, Koji, Inai, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309120/
https://www.ncbi.nlm.nih.gov/pubmed/35716319
http://dx.doi.org/10.1007/s12325-022-02194-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309120/
https://www.ncbi.nlm.nih.gov/pubmed/35716319
http://dx.doi.org/10.1007/s12325-022-02194-2

Ejemplares similares